about
Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenc...
Read More
87.17
1.84
(2.16%)
705.9K
XNYS Volume
XNYS 17 Oct, 2025 5:30 PM (EDT)
Board Meeting
The next board meeting for Glaukos Corporation is on 29 Oct 2025 for the purpose of Glaukos Corp Third Quarter Earnings Conference Call for 2025
See details
Low Financial Strength
Expensive Valuation
Technically Neutral
Momentum Trap
These stocks are the ones with poor quality and also financials and technical ranging from bad to medium score. This indicates that investors should be highly watchful with these stocks.
View Similar
Embed DVM
Glaukos Corporation Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..